Sophie Sall

Kennedy Krieger Institute · company speakers →

Sophie Sall studied cellular and molecular biology at Towson University in Towson Maryland and graduated with a Bachelor of Science with honors in 2021. Since graduation she has joined the Laterra Lab at Johns Hopkins School of Medicine and Kennedy Krieger Research Institute researching the molecular characteristics of glioblastoma and the driving forces behind treatment resistance, tumor recurrence, and the glioma stem cell phenotype under the supervision of Dr. Lopez-Bertoni and Dr. Laterra.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

International Conference on Neurology and Brain Disorders

19 October 2026 Woburn, United States “miR-590-3p delivery via nanoparticle technology inhibits recurrent GBM tumor growth by targeting multiple oncogenic nodes downstream of TGFBR2”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →